THMO (ThermoGenesis Holdings) Non Operating Income: $-2.07 Mil (TTM As of Mar. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

THMO ThermoGenesis Holdings Inc THMO
16 GF Score
Price $0.00
View Full Analysis

What is ThermoGenesis Holdings Non Operating Income?

ThermoGenesis Holdings THMO -99.00% 16 Non Operating Income is $-2.07 Mil as of Mar. 2024. GuruFocus rates THMO with a GF Score™ of 16/100.

Non Operating Income is income or expense that comes from miscellaneous sources. ThermoGenesis Holdings's Non Operating Income for the three months ended in Mar. 2024 was $0.00 Mil. Its Non Operating Income for the trailing twelve months (TTM) ended in Mar. 2024 was $-2.07 Mil.

ThermoGenesis Holdings Non Operating Income Related Terms

ThermoGenesis Holdings Non Operating Income Historical Data

* Premium members only.

The historical data trend for ThermoGenesis Holdings's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ThermoGenesis Holdings Non Operating Income Chart

ThermoGenesis Holdings Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Non Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ThermoGenesis Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Non Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
THMO
16GF Score
ThermoGenesis Holdings Inc THMO
Non Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ThermoGenesis Holdings Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Non Operating Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.07 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Non Operating Income →
What does a Non Operating Income of $-2.07 Mil mean?
ThermoGenesis Holdings (THMO) has a Non Operating Income of $-2.07 Mil as of Mar. 2024. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on ThermoGenesis Holdings and its competitors.
Is ThermoGenesis Holdings' Non Operating Income too high?
ThermoGenesis Holdings' current Non Operating Income is $-2.07 Mil. Overall, ThermoGenesis Holdings has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does ThermoGenesis Holdings' Non Operating Income compare to MSIU and MOTS?
ThermoGenesis Holdings' Non Operating Income of $-2.07 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Non Operating Income for a Medical Devices & Instruments company?
A good Non Operating Income depends on the Medical Devices & Instruments industry context. However, Non Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Non Operating Income mean?
A high Non Operating Income can signal that a stock is expensive relative to its fundamentals. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on ThermoGenesis Holdings and its competitors. ThermoGenesis Holdings's current Non Operating Income is $-2.07 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ThermoGenesis Holdings stock overvalued right now?
ThermoGenesis Holdings (THMO) has a current Non Operating Income of $-2.07 Mil. The current Non Operating Income is $-2.07 Mil. ThermoGenesis Holdings' overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Non Operating Income calculated?
Non Operating Income is calculated from a company's financial statements. For ThermoGenesis Holdings (THMO), the current Non Operating Income is $-2.07 Mil as of Mar. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ThermoGenesis Holdings Business Description

Address 2711 Citrus Road, Rancho Cordova, CA, USA, 95742
ThermoGenesis Holdings Inc develops, commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The company markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. It offers the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and CAR-TXpress platform for bio-manufacturing for immuno-oncology applications.
16GF Score

Get the complete analysis for THMO

Non Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price